Who is sponsoring Yervoy RMP?

Yervoy RMP is sponsored by Bristol-Myers Squibb.

What condition does Yervoy RMP study?

Yervoy RMP studies Advanced Melanoma, Hepatitis B, Hepatitis C.

What is the status of Yervoy RMP?

Yervoy RMP is currently COMPLETED.

Last reviewed 2022-01-26 · How we verify

Ipilimumab 60-month Pharmacovigilance Protocol for Advanced Melanoma Patients Who Are Hepatitis B and/or Hepatitis C Virus Positive in Taiwan (Yervoy RMP)

NCT02402699 COMPLETED

This protocol is being conducted to comply with the direct request from the Taiwan Food and Drug Administration (TFDA) for a 60-month intensive pharmacovigilance protocol of patients with known hepatitis B (HBV) or hepatitis C (HCV) infection, regardless of control on antiviral therapy in Taiwan and who are treated with ipilimumab for advanced (unresectable, recurrent or metastatic) Melanoma.

Details

Lead sponsor	Bristol-Myers Squibb
Status	COMPLETED
Enrolment	3
Start date	Tue Dec 15 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Thu Mar 23 2017 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Advanced Melanoma
Hepatitis B
Hepatitis C

Countries

Taiwan